Entia Biosciences Inc. an emerging leader in the field of Nutrigenomics, released today the following Annual Shareholder Letter by Marvin S. Hausman MD, Chairman and CEO.
Entia Biosciences CEO & SAB Member Invited to Chair Sessions and Speak at 17th International Functional Food ConferenceEntia Biosciences Inc. announces that Marvin S. Hausman MD, CEO, will speak on the subject - "Treatment of Anemia with a Natural Mushroom-Based Medical Food ErgoD2."
Entia Biosciences Announces Ergothioneine Study Results Protection Against Blood Vessel Oxidative StressEntia Biosciences, Inc., an emerging leader in the field of nutrigenomics, today announced the publication of a study demonstrating the antioxidant and cytoprotective effects of Ergothioneine.
Entia Biosciences Inks Major Distribution Agreement for its GROH® Brand of Beauty & Wellness Products
Entia Biosciences, Inc. today announced that it entered into an agreement with Shooting Starzz LLC Distribution Services on September 9th, 2014 to represent the GROH® product line in over 24,000 salons in nine states.
Sep 03,2014This recent article published in the Journal of Pharmacology in collaboration with Entia CEO Dr. Marvin Hausman and Entia Scientific Advisory board member Dr. Paul Vanhoutte examines the role Ergothioneine may have in protecting human endothelial cells from oxidative stress.